| Reference | </br>1:Mitoxantrone, prednimustine, and vincristine for elderly patients with aggressive non-Hodgkin/’s lymphoma. Yau JC, Germond C, Gluck S, Cripps C, Verma S, Burns BF, Koski TM, Lister DC, Goss GD.Am J Hematol. 1998 Oct;59(2):156-60. PMID: 9766801 Free Article</br>2:[Myoclonus induced by prednimustine]. Ezpeleta Echávarri D, Muñoz-Blanco JL, Diaz-Otero F, Giménez Roldán S.Neurologia. 1998 Mar;13(3):154-5. Review. Spanish. No abstract available. PMID: 9608225 </br>3:Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d/’Etude des Lymphomes Folliculaires. Groupe d/’Etude des Lymphomes de l/’Adulte. Brice P, Bastion Y, Lepage E, Brousse N, Haïoun C, Moreau P, Straetmans N, Tilly H, Tabah I, Solal-Céligny P.J Clin Oncol. 1997 Mar;15(3):1110-7. PMID: 9060552 </br>4:Combination of oral idarubicin and prednimustine in advanced breast cancer: a phase II study. Barnadas A, Mendiola C, Casado A, Villar A, Jimeno J, Clerigue M, Rosell R, Diaz-Rubio E, Cortés-Funes H, García de Paredes M.Eur J Cancer. 1997 Feb;33(2):312-5. PMID: 9135508 </br>5:A rare case of prednimustine-induced myoclonus. Monnerat C, Gander M, Leyvraz S.J Natl Cancer Inst. 1997 Jan 15;89(2):173-4. No abstract available. PMID: 8998190 </br>6:Response to cytarabine ocfosfate (YNK01) in a patient with chronic lymphocytic leukemia refractory to treatment with chlorambucil/prednisone, fludarabine, and prednimustine/mitoxantrone. Braess J, Kern W, Unterhalt M, Kaufmann CC, Ramsauer B, Schüssler M, Kaeser-Fröhlich A, Hiddemann W, Schleyer E.Ann Hematol. 1996 Oct;73(4):201-4. PMID: 8890711 </br>7:Second-line chemotherapy in human immunodeficiency virus-related non-Hodgkin/’s lymphoma: evidence of activity of a combination of etoposide, mitoxantrone, and prednimustine in relapsed patients. Tirelli U, Errante D, Spina M, Gastaldi R, Nigra E, Nosari AM, Magnani G, Vaccher E.Cancer. 1996 May 15;77(10):2127-31. PMID: 8640681 Free Article</br>8:Prednimustine, mitoxantrone (PmM) vs cyclophosphamide, vincristine, prednisone (COP) for the treatment of advanced low-grade non-Hodgkin/’s lymphoma. German Low-Grade Lymphoma Study Group. Unterhalt M, Herrmann R, Tiemann M, Parwaresch R, Stein H, Trümper L, Nahler M, Reuss-Borst M, Tirier C, Neubauer A, Freund M, Kreuser ED, Dietzfelbinger H, Bodenstein H, Engert A, Stauder R, Eimermacher H, Landys K, Hiddemann W.Leukemia. 1996 May;10(5):836-43. PMID: 8656680 </br>9:CEP regimen (CCNU, etoposide, prednimustine) for relapsed/refractory Hodgkin/’s disease. Zinzani PL, Barbieri E, Bendandi M, Perini F, Gherlinzoni F, Neri S, Ammendolia I, Salvucci M, Babini L, Fiacchini M, et al.Tumori. 1994 Dec 31;80(6):438-42. PMID: 7900233 </br>10:Total body irradiation and prednimustine in chronic lymphocytic leukemia and low grade non-Hodgkin/’s lymphomas. A 9-year experience at a single institution. Roncadin M, Arcicasa M, Zagonel V, Bortolus R, Valeri P, Pinto A, De Paoli A, Franchin G, Carbone A, Trovò MG.Cancer. 1994 Aug 1;74(3):978-84. PMID: 8039128 Free Article
|
